Top compounds associated with response to DLX1


Feature Type Standardized
Nominal ANOVA
mRNA Axitinib CTRPv2 pan-cancer AAC 0.19 5e-08
mRNA FK866 GDSC1000 pan-cancer AAC 0.15 8e-07
mRNA regorafenib CTRPv2 pan-cancer AAC 0.19 8e-07
mRNA cediranib CTRPv2 pan-cancer AAC 0.27 1e-06
mRNA SB-225002 CTRPv2 pan-cancer AAC 0.15 1e-06
mRNA Ki8751 CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA tivozanib CTRPv2 pan-cancer AAC 0.16 8e-06
mRNA lenvatinib CTRPv2 pan-cancer AAC 0.16 8e-06
mRNA MLN2480 CTRPv2 pan-cancer AAC 0.24 1e-05
Download CSV